Cipla reported INR8.01B in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Cipla CIPLA:IN INR 8.01B 120.6M
Dr.Reddys Laboratories DRRD:IN INR 12.44B 1.3B
Sun Pharmaceuticals SUNP:IN INR 21.66B 962.1M
UPL UPLL:IN INR 10.87B 2.73B